comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 05:39:18 - browse：397

A stethoscope lays on banknotes next to a calculator, all on top of a insurance application form — coverage from STAT — Adobe

Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report.

But investors have found pockets of profits by backing companies involved in enrolling seniors in MA plans and keeping track of them once they’re there. They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.

Overall, private equity investors made only 4 investments in Medicare Advantage-related companies last year, compared with 12 in 2022, down from a peak of 19 in 2021, per the Private Equity Stakeholder Project, a group focused on holding private equity firms accountable for their impacts on people and the planet, according to its website.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Kaiser's Risant Health gobbled up Geisinger. Who is next?

explore

knowledge

WSS

Johnson & Johnson sues to stop Medicare negotiation

Shifting the focus from loneliness to social health

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Let's speed up science by embracing open access publishing

With trial win, GSK could get blood cancer drug back on market

hotspot

comprehensive

knowledge

At least 13 dead in Texas as scorching temps continue

Twill hunts for pharma partner to market its depression app

At least 13 dead in Texas as scorching temps continue

A Theranos scientist

Novavax promises a turnaround & Lilly roils the obesity market

FDA seeking to stop procedures at two unregulated stem cell clinics

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Trump demands the U.S. pay no more for drugs than other countries … again

Biden administration sends mixed signals on US soldier who crossed into North Korea

focus

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

A look at other Americans who have crossed into North Korea over the years

NIH documents show early flaws of $1.6 billion long Covid program

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

What we know about the American soldier detained in North Korea

With trial win, GSK could get blood cancer drug back on market

explore

knowledge

Wikipedia

hotspot